Daily Stock Analysis, ZBH, Zimmer Biomet Holdings Inc, priceseries

Zimmer Biomet Holdings Inc. Daily Stock Analysis
Stock Information
Open
120.28
Close
116.68
High
120.28
Low
115.72
Previous Close
120.44
Daily Price Gain
-3.76
YTD High
129.60
YTD High Date
Jan 5, 2022
YTD Low
105.23
YTD Low Date
Feb 8, 2022
YTD Price Change
-8.59
YTD Gain
-6.86%
52 Week High
174.11
52 Week High Date
Apr 29, 2021
52 Week Low
105.23
52 Week Low Date
Feb 8, 2022
52 Week Price Change
-34.17
52 Week Gain
-22.65%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 4. 2017
97.37
Feb 14. 2017
109.54
28 Trading Days
12.50%
Link
LONG
Jul 24. 2018
108.34
Aug 9. 2018
117.02
12 Trading Days
8.01%
Link
LONG
Jan 30. 2019
102.96
Mar 6. 2019
116.69
24 Trading Days
13.34%
Link
LONG
Jul 15. 2019
116.18
Aug 14. 2019
128.93
22 Trading Days
10.98%
Link
LONG
Jul 13. 2020
116.11
Aug 4. 2020
127.21
16 Trading Days
9.56%
Link
LONG
Apr 5. 2021
157.06
May 4. 2021
168.55
21 Trading Days
7.31%
Link
Company Information
Stock Symbol
ZBH
Exchange
NYSE
Company URL
http://www.zimmerbiomet.com
Company Phone
5742676131
CEO
David C. Dvorak
Headquarters
Indiana
Business Address
345 EAST MAIN STREET, WARSAW, IN 46580
Sector
-
Industry Category
Health Services
Industry Group
Medical Appliances & Equipment
CIK
0001136869
About

Zimmer Biomet Holdings, Inc. designs, manufactures and markets orthopaedic reconstructive products, sports medicine, extremities and trauma products; craniomaxillofacial and thoracic products; dental implants; and related surgical products. The company operates through three geographical segments: America, Europe and Asia Pacific. The Americas segment comprises principally of the U.S. and includes other North, Central and South American markets. The Europe segment comprises principally of Europe and includes the Middle East and African markets. The Asia Pacific segment comprises primarily of Japan and includes other Asian and Pacific markets. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Zimmer Biomet Holdings was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

Description

Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through four segments: Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic (CMF), and Dental. The company provides orthopedic reconstructive products, such as knee and hip reconstructive products; S.E.T. products, including surgical, sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products; and bone cement and spinal fusion stimulators. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopaedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.